ACG South Florida 18th Annual Healthcare M&A Panel Discussion

Josh Peck is the Chief Operating Officer where he leads enterprise operations and execution across the organization. In this role, Josh is focused on strengthening alignment, improving operational consistency, and supporting scalable growth that advances physician leadership, practice performance, and high-quality patient care.

Josh brings more than 20 years of experience across healthcare operations, finance, and organizational growth, with deep expertise supporting physician-led organizations at scale. He is known for his disciplined, solutions-oriented leadership style and his ability to translate strategy into practical execution that works in real-world clinical and operational environments.

Prior to joining The Specialty Alliance, Josh served as Chief Development Officer of Solaris Health, where he helped guide the organization’s strategic and organic growth from its founding in 2020. During his tenure, Solaris grew into the nation’s largest independent urology network, supporting more than 750 urologic providers across 14 states before partnering with The Specialty Alliance.

Earlier in his career, Josh spent 14 years with MEDNAX, holding roles of increasing responsibility across business development, mergers and acquisitions, and practice integration. He also served as Director of Practice Integration for American Anesthesiology, where he led onboarding and operational alignment during periods of rapid expansion.

Josh holds a Bachelor of Science in Finance from the University of Florida.

Howard is a seasoned strategic advisor and board member with more than three decades of leadership across M&A, organizational transformation, operational excellence, governance, and finance. He serves on the boards of Immorta Bio, JScreen, the Palm Beach County Life Sciences Advisory Council, and Breakthrough T1D, contributing expertise that spans biotech innovation, healthcare access and testing, AI-based drug discovery and commercialization, and regional life sciences economic development.

Throughout his career including serving as EY’s Americas Health Sciences Leader, Howard has guided global life sciences and healthcare organizations through complex growth initiatives — from scaling emerging healthcare platforms to advising senior executives and investors on high‑impact strategic decisions. His work includes leading major transformation programs, driving deal implementation and integration, shaping commercialization strategies, and building extensive networks of industry leaders, innovators, and capital partners.

Howard is deeply engaged in the application of AI and advanced analytics to accelerate scientific discovery, strengthen operational performance, and enhance decision‑making. He advises organizations on AI‑enabled strategy, governance, and responsible adoption, helping companies translate emerging technologies into measurable enterprise value.

Matt has over 15 years of middle market private equity investment experience. Formerly a Principal at Atlantic Street Capital (ASC), Matt worked on all aspects of the investment process with a particular focus on deal sourcing, due diligence, financing, and execution. Matt pursued investments in the healthcare, business services, consumer, and multi-unit retail sectors. Prior to ASC, Matt was a member of the investment team at the Watermill Group, focusing on the industrials and distribution sectors. Matt began his career in secondary private equity investing at Newbury Partners and investment banking at Lazard Frères & Co. Matt has a B.S.B.A. from Georgetown University. Matt lives with his wife and three children in West Palm Beach, FL.